Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 12
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Senti Biosciences Holdings Inc
SNTI
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.3120
-0.0024
-0.76%
Ult. Agg.: Oct 12, 3:45 PM
$0.3102
-0.0042
-1.34%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
Senti Biosciences Financials
Senti Biosciences (SNTI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from
Benzinga Newsdesk
PRO
Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 11.11 percent. This is a 20.9 percent increase over losses of $(0.67) per share
Benzinga Newsdesk
PRO
Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share
Benzinga Newsdesk
PRO
Senti Biosciences Q2 EPS $(0.56) Beats $(0.90) Estimate
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.78 percent. This is a 77.14 percent increase over losses of $(2.45) per share from
Benzinga Newsdesk
PRO
Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY
Benzinga Newsdesk
PRO
Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.
Benzinga Newsdesk
